Sempra Energy (NYSE:SRE) updated its FY20 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $7.20-7.80 for the period, compared to the Thomson Reuters consensus estimate of $7.06. Sempra Energy also updated its FY 2020
After-Hours guidance to 7.20-7.80 EPS.
Several equities research analysts have weighed in on the stock. Seaport Global Securities started coverage on shares of Sempra Energy in a report on Monday, June 15th. They issued a buy rating and a $142.00 price target for the company. JPMorgan Chase & Co. decreased their price target on shares of Sempra Energy from $139.00 to $136.00 and set a neutral rating for the company in a report on Wednesday, May 27th. Zacks Investment Research cut shares of Sempra Energy from a buy rating to a hold rating and set a $138.00 price target for the company. in a report on Monday, April 13th. UBS Group raised their price target on shares of Sempra Energy from $160.00 to $173.00 and gave the stock a buy rating in a report on Friday, June 5th. Finally, Bank of America raised shares of Sempra Energy from a neutral rating to a buy rating and set a $135.00 price target for the company in a report on Friday, June 12th. Eight analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of Buy and an average price target of $147.75.
Shares of NYSE SRE traded down $0.89 during trading on Tuesday, hitting $117.23. The company had a trading volume of 1,744,049 shares, compared to its average volume of 1,928,036. The stock has a fifty day simple moving average of $123.66 and a two-hundred day simple moving average of $134.80. Sempra Energy has a fifty-two week low of $88.00 and a fifty-two week high of $161.87. The firm has a market capitalization of $32.94 billion, a price-to-earnings ratio of 14.33, a price-to-earnings-growth ratio of 2.14 and a beta of 0.74. The company has a quick ratio of 0.43, a current ratio of 0.45 and a debt-to-equity ratio of 1.02.
Sempra Energy (NYSE:SRE) last announced its earnings results on Monday, May 4th. The utilities provider reported $3.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.26 by $0.82. The business had revenue of $3.03 billion for the quarter, compared to analyst estimates of $3.24 billion. Sempra Energy had a net margin of 22.32% and a return on equity of 11.30%. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.92 earnings per share. On average, analysts anticipate that Sempra Energy will post 7.34 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Friday, June 26th will be given a dividend of $1.045 per share. The ex-dividend date of this dividend is Thursday, June 25th. This represents a $4.18 dividend on an annualized basis and a yield of 3.57%. Sempra Energy's payout ratio is presently 61.65%.
In other Sempra Energy news, CFO Trevor I. Mihalik sold 10,281 shares of Sempra Energy stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $124.16, for a total transaction of $1,276,488.96. Following the transaction, the chief financial officer now directly owns 15,464 shares of the company's stock, valued at $1,920,010.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.09% of the stock is owned by insiders.
About Sempra Energy
Sempra Energy, together with its subsidiaries, invests in, develops, and operates energy infrastructure, as well as provides electric and gas services in the United States and internationally. The company's San Diego Gas & Electric Company segment generates, transmits, and distributes electricity; and supplies natural gas.
Further Reading: What is a put option?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
15 Healthcare Stocks that Analysts Love
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems and other healthcare stocks, it can be hard to identify which healthcare companies are going to outperform the market.
Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same healthcare stock.
This slide show lists the 15 healthcare companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "15 Healthcare Stocks that Analysts Love".
